Seven Fleet Capital Management LP 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Seven Fleet Capital Management LP disclosed 115 US equity positions worth $318.3m in its Q1 2026 13F filing. The largest position was CG ONCOLOGY INC at 30.6% of the reported book, followed by TNGX and RVMD.
What did Seven Fleet Capital Management LP own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | 30.6% | $97.4m | 1,439,393 | – | ||
| 2 | TNGX TANGO THERAPEUTICS INC | Healthcare | 3.3% | $10.5m | 502,012 | – | |
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.5% | $7.9m | 80,792 | – | |
| 4 | TYRA TYRA BIOSCIENCES INC | Healthcare | 2.4% | $7.5m | 195,685 | – | |
| 5 | LQDA LIQUIDIA CORPORATION | Healthcare | 2.2% | $7.1m | 187,876 | – | |
| 6 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 2.2% | $7.1m | 209,547 | – | |
| 7 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 2.1% | $6.7m | 2,947,826 | – | |
| 8 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 2.0% | $6.4m | 164,030 | – | |
| 9 | PCVX VAXCYTE INC | Healthcare | 2.0% | $6.3m | 108,450 | – | |
| 10 | TANGO THERAPEUTICS INC | 2.0% | $6.3m | 300,648 | – | ||
| 11 | COGT COGENT BIOSCIENCES INC | Healthcare | 1.8% | $5.8m | 149,399 | – | |
| 12 | AVALO THERAPEUTICS INC | 1.7% | $5.4m | 360,064 | – | ||
| 13 | MINERVA NEUROSCIENCES INC | 1.7% | $5.4m | 889,254 | – | ||
| 14 | CGON CG ONCOLOGY INC | Healthcare | 1.6% | $5.1m | 75,758 | – | |
| 15 | PHVS PHARVARIS N V | Healthcare | 1.5% | $4.9m | 172,731 | – | |
| 16 | ABVX ABIVAX SA | Healthcare | 1.5% | $4.8m | 43,052 | – | |
| 17 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.4% | $4.6m | 54,258 | – | |
| 18 | PHARVARIS N V | 1.3% | $4.1m | 143,966 | – | ||
| 19 | CYTK CYTOKINETICS INC | Healthcare | 1.3% | $4.0m | 61,269 | – | |
| 20 | SLNOEUR SOLENO THERAPEUTICS INC | 1.2% | $3.9m | 115,770 | – | ||
| 21 | ENLIVEN THERAPEUTICS INC | 1.2% | $3.7m | 95,253 | – | ||
| 22 | ERAS ERASCA INC | Healthcare | 1.1% | $3.6m | 222,468 | – | |
| 23 | ROIV ROIVANT SCIENCES LTD | Healthcare | 1.1% | $3.6m | 128,168 | – | |
| 24 | CYTOMX THERAPEUTICS INC. | 1.1% | $3.4m | 714,000 | – | ||
| 25 | AVTX AVALO THERAPEUTICS INC | Healthcare | 1.0% | $3.2m | 213,819 | – | |
| 26 | CENTURY THERAPEUTICS INC | 1.0% | $3.2m | 1,400,000 | – | ||
| 27 | EPRX EUPRAXIA PHARMACEUTICALS INC | 1.0% | $3.1m | 433,515 | – | ||
| 28 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 0.9% | $2.9m | 86,283 | – | |
| 29 | TSHA TAYSHA GENE THERAPIES INC | Healthcare | 0.9% | $2.8m | 625,708 | – | |
| 30 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.9% | $2.8m | 12,179 | – | |
| 31 | CMPX COMPASS THERAPEUTICS INC | 0.9% | $2.7m | 516,972 | – | ||
| 32 | DMRA DAMORA THERAPEUTICS INC | Healthcare | 0.8% | $2.6m | 101,248 | – | |
| 33 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.8% | $2.6m | 128,487 | – | ||
| 34 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.8% | $2.6m | 257,738 | – | |
| 35 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 0.7% | $2.4m | 14,055 | – | |
| 36 | COMPASS THERAPEUTICS INC | 0.7% | $2.2m | 423,566 | – | ||
| 37 | DIANTHUS THERAPEUTICS INC | 0.7% | $2.2m | 26,551 | – | ||
| 38 | EUPRAXIA PHARMACEUTICALS INC | 0.6% | $2.0m | 276,000 | – | ||
| 39 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 0.6% | $1.9m | 99,887 | – | |
| 40 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.6% | $1.9m | 69,571 | – | |
| 41 | SOLENO THERAPEUTICS INC | 0.6% | $1.8m | 54,000 | – | ||
| 42 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.6% | $1.8m | 3,393 | – | |
| 43 | CTMX CYTOMX THERAPEUTICS INC. | Healthcare | 0.5% | $1.7m | 371,398 | – | |
| 44 | LONA LEONABIO INC | 0.5% | $1.7m | 164,676 | – | ||
| 45 | SVRA SAVARA INC | Healthcare | 0.5% | $1.6m | 295,688 | – | |
| 46 | CATX PERSPECTIVE THERAPEUTICS INC | 0.5% | $1.6m | 379,082 | – | ||
| 47 | ASMB ASSEMBLY BIOSCIENCES INC | Healthcare | 0.5% | $1.6m | 56,147 | – | |
| 48 | SAB BIOTHERAPEUTICS INC | 0.5% | $1.5m | 400,000 | – | ||
| 49 | NERV MINERVA NEUROSCIENCES INC | 0.5% | $1.5m | 248,476 | – | ||
| 50 | ZLAB ZAI LAB LTD | Healthcare | 0.5% | $1.5m | 77,858 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.